Lung Cancer: References

content provided by Healthwise

References

Citations

1. American Cancer Society (2005). What are the key statistics for lung cancer? Detailed Guide: Lung Cancer. Available online: http://www.cancer.org/docroot/CRI/content/CRI_2_4_1x_What_Are_the_Key_Statistics_About_Lung_Cancer_15.asp?sitearea=.

2. Miller YE (2004). Lung cancer and other pulmonary neoplasms. In L Goldman, D Ausiello, eds., Cecil Textbook of Medicine, 22nd ed., pp. 1201–1208. Philadelphia: Saunders.

3. Crawford J (2004). Lung cancer. In DC Dale, DD Federman, eds., ACP Medicine, section 12, chap. 8. New York: WebMD.

4. Godtfredsen NS, et al. (2005). Effect of smoking reduction on lung cancer risk. JAMA, 294(12): 1505–1510.

5. Jablons D, et al. (2003). Neoplasms of the lung. In LW Way, GM Doherty, eds., Current Surgical Diagnosis and Treatment, 11th ed., pp. 395–407. New York: McGraw-Hill.

6. Bain C, et al. (2004). Lung cancer rates in men and women with comparable histories of smoking. Journal of the National Cancer Institute, 96(11): 826–834.

7. National Toxicology Program, U.S. Department of Health and Human Services (2005). Report on Carcinogens, 11th ed. Available online: http://ntp-server.niehs.nih.gov/ntp/roc/toc11.html.

8. Annema JT, et al. (2005). Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer. JAMA, 294(8): 931–936.

9. Humphrey LL, et al. (2004). Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: An update for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 140(9): 740–753.

10. National Cancer Institute (2005). Lung Cancer PDQ: Screening–Health Professional Version. Available online: http://www.cancer.gov/cancertopics/pdq/screening/lung/healthprofessional.

11. Winton T, et al. (2005). Vinorelbine plus cisplatin vs. observation in resected non–small cell lung cancer. New England Journal of Medicine, 352(25): 2589–2597.

12. Fox JL, et al. (2004). The effect of smoking status on survival following radiation therapy for non–small cell lung cancer. Lung Cancer, 44(3): 287–293.

13. Dasgupta P, et al. (2006). Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proceedings of the National Academy of Sciences, 103(16): 6332–6337.

14. Simon CJ, Dupuy DE (2005). Current role of image-guided ablative therapies in lung cancer. Expert Review of Anticancer Therapy, 5(4): 657–666.

15. International Adjuvant Lung Cancer Trial Collaborative Group (2004). Cisplatin-based adjuvant chemotherapy in patients with completely resected non–small-cell lung cancer. New England Journal of Medicine, 350(4): 351–360.

16. Spira A, Ettinger DS (2004). Multidisciplinary management of lung cancer. New England Journal of Medicine, 350(4): 379–392.

17. Schabath MB, et al. (2005). Dietary phytoestrogens and lung cancer. JAMA, 294(12): 1493–1504.

18. Goodman GE, et al. (2004). The beta-carotene and retinol efficacy trial: Incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. Journal of the National Cancer Institute, 96(23): 1743–1750.

19. Food and Drug Administration (2004). FDA statement on Iressa. FDA Public Health Web Notification. Available online: http://www.fda.gov/bbs/topics/news/2004/new01145.html.

20. U.S. Food and Drug Administration (2006). FDA approves new combination therapy for lung cancer. FDA News. Available online: http://www.fda.gov/bbs/topics/NEWS/2006/NEW01488.html.

21. Chesnutt MS, Prendergast TJ (2005). Pulmonary neoplasms. In LM Tierney Jr et al., eds., Current Medical Diagnosis and Treatment, 44th ed., pp. 262–271. New York: McGraw-Hill.

22. National Cancer Institute (2006). Small Cell Lung Cancer PDQ: Treatment—Health Professional Version. Available online: http://www.cancer.gov/cancertopics/pdq/treatment/small-cell-lung/healthprofessional.

23. Auperin A, et al. (1999). Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. New England Journal of Medicine, 341(7): 476–484.

Other Works Consulted

• National Comprehensive Cancer Network and American Cancer Society (2004). Lung Cancer Treatment Guidelines for Patients, version II. Available online: http://www.nccn.org/patients/patient_gls/_english/_lung/contents.asp.

• National Comprehensive Cancer Network and American Cancer Society (2005). Non–Small Cell Lung Cancer, version 2.2005. Available online: http://www.nccn.org/professionals/physician_gls/PDF/nscl.pdf.

• National Comprehensive Cancer Network and American Cancer Society (2005). Small Cell Lung Cancer, version 1.2006. Available online: http://www.nccn.org/professionals/physician_gls/PDF/sclc.pdf.

• Neville A (2004). Lung cancer. Clinical Evidence (13): 1–21.

E-mail This | Print This Previous Chapter | Next Chapter

Last updated:	June 12, 2006
Author:	Shannon Erstad, MBA/MPH
Reviewed By:	Caroline S. Rhoads, MD - Internal Medicine, Michael Seth Rabin, MD - Medical Oncology
Editors:	Kathleen M. Ariss, MS, Pat Truman